NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system, or CNS, diseases.
$2.22 -0.17 (-7.11%)
As of 01/24/2023 16:00:00 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Micro cap
GICS sector: Health Care
Industry: Biotechnology
Index country: USA
Country of incorporation: USA
IPO date: 07/01/2014
Outstanding shares: 5,340,193
Average volume: 246,729
Market cap: $11,801,827
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
Sedol:
Valuation (See tab for details)
PE ratio: -0.60
PB ratio: 11.87
PS ratio: 3.92
Return on equity: 6,909.87%
Net income %: -1,690.90%